
CRS-3123
CAS No. 1013915-71-3
CRS-3123( CRS3123 | REP 3123 )
Catalog No. M10078 CAS No. 1013915-71-3
A novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 1323 | Get Quote |
![]() ![]() |
50MG | 2682 | Get Quote |
![]() ![]() |
100MG | 3600 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCRS-3123
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI).
-
DescriptionA novel diaryldiamine that inhibits bacterial methionyl-tRNA synthetases in Gram-positive bacteria as a novel agent to treat Clostridium difficile infection (CDI); inhibits de novo toxin production in high cell density, stationary phase cultures of C. difficile at 1 mg/L; demonstrates efficacy in the hamster model of CDI and is superior to vancomycin 0.5 mg/kg in CDI model.Bacterial Infection Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsCRS3123 | REP 3123
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInfection
-
IndicationBacterial Infection
Chemical Information
-
CAS Number1013915-71-3
-
Formula Weight515.264
-
Molecular FormulaC19H21Br2N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (194.84 mM)
-
SMILESBrC1=CC(Br)=C2OCC[C@H](C2=C1)NCCCNC3=CC(C4SC=CC4N3)=O
-
Chemical Name5-((3-(((R)-6,8-dibromochroman-4-yl)amino)propyl)amino)-3a,7a-dihydrothieno[3,2-b]pyridin-7(4H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Citron DM, et al. J Antimicrob Chemother. 2009 May;63(5):972-6.
2. Ochsner UA, et al. J Antimicrob Chemother. 2009 May;63(5):964-71.
3. Critchley IA, et al. J Antimicrob Chemother. 2009 May;63(5):954-63.
molnova catalog



related products
-
Bedaquiline fumarate
Bedaquiline fumarate (R403323, TMC207 fumarate, R207910 fumarate) is a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.
-
Salicyl-AMS
Salicyl-AMS is an inhibitor of mycobacterium auxin biosynthesis that inhibits the growth of mycobacterium in the presence of iron deficiency in vitro.
-
Fosfomycin Disodium
Fosfomycin is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis.